Dendritic Cells
Dendritic cells (DCs) have long been recognized as the most potent antigen-producing cells with the capacity to initiate naive T cell response in vitro and in vivo. During their differentiation and maturation pathways, dendritic cells can efficiently capture, process and present antigens for T cell activation making DCs an attractive choice for cancer vaccines.
Tools, technologies, antibodies and detection methods from Beckman Coulter are helping researchers take a more holistic approach to understanding the immune response and how it plays out in pathogenic disease.
Dendritic Cells Resources
- Filter by:
| Title | Description |
|---|---|
| {C00ACFAF-8661-4DF6-8BA5-A7A099A7BA9C} |
Additional Research Topics and Information
-
Research Areas
-
Immunotherapy
- About Immunotherapy
- CAR-T Cells: Immuno-oncology Therapeutics
- About Viral Vectors
- Pediatric Immunotherapy
- Immunotherapy Research: Supporting Products
- Immunotherapy Shows Renewed Promise for Cancer Therapies
- CRISPR for Immunotherapy
- Characterizing Viral Vectors: Analyzing rAAV Vector Homogeneity
- Developing and Producing Viral Vectors: Powering Forward Momentum for the Future of Gene Therapy
- 3D Cell Culture
- Dendritic Cells
-
Exosomes
- About Exosomes
- Applied Exosome Research
- Apoptosis Detection
- Simplifying Exosome Isolation
- Basic Exosome Research
- Cell-Based Assays
- Cell Signaling
- Exosomes Take Disease Modeling to the Next Level: From the Cage to the Plate
- Deciphering Disease using Exosome Biomarkers
- Targeting Efficient Drug Delivery With Exosome Nanoparticles
- Exosome Isolation
- Isolation and Characterization of Exosomes for Assays Approaches
- Exosomes: Moving Cancer Research Forward ~100 nm at a Time
- Instruments used in exosome research
- Nanoparticle Research
- Stem Cells
- Biologics
-
Immunotherapy
Contact Us